Jane Street
IMVT icon

Jane Street’s Immunovant IMVT Stock Holding History

Jane Street’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-84,312
Closed -$2.57M – 12308
2026
Q1 		$2.09M Buy
+84,312
New +$2.18M ﹤0.01% 4991
2025
Q4 		– Sell
-337,666
Closed -$7.53M – 11728
2025
Q3 		$5.44M Buy
+337,666
New +$5.47M ﹤0.01% 3305
2025
Q2 		– Sell
-52,420
Closed -$793K – 10211
2025
Q1 		$896K Sell
52,420
-453,171
-90% -$9.48M ﹤0.01% 5776
2024
Q4 		$12.5M Buy
505,591
+181,426
+56% +$5.15M ﹤0.01% 1686
2024
Q3 		$9.24M Buy
324,165
+183,848
+131% +$5.42M ﹤0.01% 1987
2024
Q2 		$3.7M Buy
140,317
+72,712
+108% +$2.07M ﹤0.01% 3442
2024
Q1 		$2.18M Sell
67,605
-546,736
-89% -$19.9M ﹤0.01% 3970
2023
Q4 		$25.9M Buy
614,341
+285,829
+87% +$10.5M 0.01% 1067
2023
Q3 		$12.6M Buy
328,512
+167,466
+104% +$3.79M ﹤0.01% 1532
2023
Q2 		$3.06M Buy
161,046
+63,624
+65% +$1.19M ﹤0.01% 3463
2023
Q1 		$1.51M Sell
97,422
-221,649
-69% -$3.85M ﹤0.01% 4293
2022
Q4 		$5.66M Buy
319,071
+302,965
+1,881% +$3.81M ﹤0.01% 2316
2022
Q3 		$90K Buy
+16,106
New +$78.7K ﹤0.01% 8702
2022
Q2 		– Sell
-41,178
Closed -$226K – 10191
2022
Q1 		$226K Buy
41,178
+9,424
+30% +$58.7K ﹤0.01% 8860
2021
Q4 		$270K Sell
31,754
-47,002
-60% -$388K ﹤0.01% 8366
2021
Q3 		$684K Sell
78,756
-38,962
-33% -$351K ﹤0.01% 6693
2021
Q2 		$1.24M Buy
117,718
+104,172
+769% +$1.45M ﹤0.01% 5348
2021
Q1 		$217K Buy
+13,546
New +$357K ﹤0.01% 8152
2020
Q4 		– Sell
-14,713
Closed -$518K – 7769
2020
Q3 		$518K Sell
14,713
-11,608
-44% -$349K ﹤0.01% 5095
2020
Q2 		$640K Buy
26,321
+14,331
+120% +$307K ﹤0.01% 4703
2020
Q1 		$186K Buy
+11,990
New +$180K ﹤0.01% 4684

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's IMVT Position: Q2 2026 in Review

Jane Street sold out of Immunovant (IMVT) in Q2 2026, closing a stake of 84,312 shares — an estimated $2.57M sold.

Jane Street first reported a position in IMVT in Q1 2020 and held it in 21 quarters. The position peaked at $25.9M in Q4 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Jane Street reported no remaining Immunovant position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 84,312 Immunovant shares in Q2 2026, an estimated $2.57M.
  • Jane Street first reported a position in Immunovant in Q1 2020 and held it in 21 quarters.
  • Jane Street's Immunovant position peaked at $25.9M in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.